Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy Frech

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Therapeutic Advances in Musculoskeletal Disease|August 5, 2025
Cardio-rheumatology: integrated care and the opportunities for personalized medicineTania Ruiz Maya, Ashley Ciosek, Tracy Frech, et al.
Journal of Health Care for the Poor and Underserved|November 12, 2013
Prevalence of fracture and osteoporosis risk factors in American Indian and Alaska Native peopleTracy Frech, Khe-ni Ma, Elizabeth D Ferrucci, et al.
International Journal of Rheumatology|September 16, 2011
Low-dose naltrexone for pruritus in systemic sclerosisTracy Frech, Kirsten Novak, Monica P Revelo, et al.
Health and Quality of Life Outcomes|October 6, 2010
Valuation of scleroderma and psoriatic arthritis health states by the general publicDinesh Khanna, Tracy Frech, Puja P Khanna, et al.
Arthritis Research & Therapy|September 5, 2019
A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcersVivek Nagaraja, Cathie Spino, Erica Bush, et al.
Frontiers in Immunology|September 25, 2018
Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?Cosimo Bruni, Tracy Frech, Mirko Manetti, et al.
Arthritis Research & Therapy|February 25, 2014
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label studyAvram Goldberg, Thomas Geppert, Elena Schiopu, et al.
The Journal of Rheumatology|June 17, 2016
The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral TreprostinilAmi A Shah, Elena Schiopu, Soumya Chatterjee, et al.
The Journal of Rheumatology|November 17, 2018
Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials ConsortiumZsuzsanna H McMahan, Tracy Frech, Veronica Berrocal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2020
ReplyRobert Spiera, Lorinda Chung, Tracy Frech, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Therapeutic Advances in Musculoskeletal Disease|August 5, 2025
Cardio-rheumatology: integrated care and the opportunities for personalized medicineTania Ruiz Maya, Ashley Ciosek, Tracy Frech, et al.
Journal of Health Care for the Poor and Underserved|November 12, 2013
Prevalence of fracture and osteoporosis risk factors in American Indian and Alaska Native peopleTracy Frech, Khe-ni Ma, Elizabeth D Ferrucci, et al.
International Journal of Rheumatology|September 16, 2011
Low-dose naltrexone for pruritus in systemic sclerosisTracy Frech, Kirsten Novak, Monica P Revelo, et al.
Health and Quality of Life Outcomes|October 6, 2010
Valuation of scleroderma and psoriatic arthritis health states by the general publicDinesh Khanna, Tracy Frech, Puja P Khanna, et al.
Arthritis Research & Therapy|September 5, 2019
A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcersVivek Nagaraja, Cathie Spino, Erica Bush, et al.
Frontiers in Immunology|September 25, 2018
Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?Cosimo Bruni, Tracy Frech, Mirko Manetti, et al.
Arthritis Research & Therapy|February 25, 2014
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label studyAvram Goldberg, Thomas Geppert, Elena Schiopu, et al.
The Journal of Rheumatology|June 17, 2016
The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral TreprostinilAmi A Shah, Elena Schiopu, Soumya Chatterjee, et al.
The Journal of Rheumatology|November 17, 2018
Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials ConsortiumZsuzsanna H McMahan, Tracy Frech, Veronica Berrocal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2020
ReplyRobert Spiera, Lorinda Chung, Tracy Frech, et al.
Pageof 6